10.30
5.78%
+0.61
Vir Biotechnology Inc (VIR) 最新ニュース
Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for ... - Business Wire
Business Wire
Amalgamated Bank Trims Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Defense World
Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer - Quantisnow
Quantisnow
Vir Biotech gets U.S. funding for flu-prevention antibody - Yahoo Canada Shine On
Yahoo Canada Shine On
Antibody Treatments for COVD-19 Face Challenges in the U.S. - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive ... - The Malaysian Reserve
The Malaysian Reserve
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive ... - Financial Times
Financial Times
Vir Biotechnology (VIR) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Vir Biotech gets U.S. funding for flu-prevention antibody - Yahoo Canada Shine On
Yahoo Canada Shine On
Analyst Forecasts For Vir Biotechnology, Inc. (NASDAQ:VIR) Are Surging Higher - Yahoo News Australia
Yahoo News Australia
Are Robust Financials Driving The Recent Rally In Vir Biotechnology, Inc.'s (NASDAQ:VIR) Stock? - Yahoo News UK
Yahoo News UK
FY2024 Earnings Forecast for Vir Biotechnology, Inc. (NASDAQ:VIR) Issued By HC Wainwright - Defense World
Defense World
Biotech Stocks Accelerate Efforts for Coronavirus Treatments - Yahoo Singapore News
Yahoo Singapore News
Vir Biotechnology, Inc. (VIR) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Movies Canada
Yahoo Movies Canada
Vir Biotechnology, Inc. (NASDAQ:VIR) to Post FY2024 Earnings of ($3.13) Per Share, HC Wainwright Forecasts - MarketBeat
MarketBeat
Vir Biotechnology (NASDAQ:VIR) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Vir Biotechnology (NASDAQ:VIR) Stock Rating Reaffirmed by HC Wainwright - Defense World
Defense World
Analysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates - Yahoo Finance
Yahoo Finance
Antibody Treatments for COVD-19 Face Challenges in the U.S. - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Vir Biotechnology's (VIR) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
MarketBeat
Antibody Treatments for COVD-19 Face Challenges in the U.S. - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%: Read This Before Placing a Bet - Yahoo Finance
Yahoo Finance
Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings) - Vir Biotechnology (NASDAQ:VIR) - Benzinga
Benzinga
Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Yousif Capital Management LLC - Defense World
Defense World
Federated Hermes Inc. Purchases New Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Defense World
Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings) - Vir Biotechnology (NASDAQ:VIR) - Benzinga
Benzinga
Vir Biotechnology, Inc. (VIR) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo New Zealand News
Yahoo New Zealand News
Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Boosting Their Estimates - Simply Wall St
Simply Wall St
(VIR) Investment Report - Stock Traders Daily
Stock Traders Daily
JPMorgan Chase & Co. Increases Vir Biotechnology (NASDAQ:VIR) Price Target to $12.00 - Defense World
Defense World
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Defense World
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
MarketBeat
Vir Biotechnology First Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Simply Wall St
Handelsbanken Fonder AB Purchases 9300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Defense World
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Defense World
CFOs depart Vir, Cellectis - BioCentury
BioCentury
Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders (NASDAQ:VIR) - Seeking Alpha
Seeking Alpha
Earnings call: Vir Biotechnology reports Q1 2024 financials, pipeline progress - Investing.com
Investing.com
Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $12.00 - MarketBeat
MarketBeat
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Vir Biotechnology Inc. (VIR) Tops Q1 EPS by 57c - StreetInsider.com
StreetInsider.com
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Finance
Yahoo Finance
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks Investment Research
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024 - Business Wire
Business Wire
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Defense World
With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing - Yahoo Finance
Yahoo Finance
What Makes Vir Biotechnology (VIR) a New Buy Stock
Zacks Investment Research
What Makes Vir Biotechnology (VIR) a New Buy Stock - Yahoo Finance
Yahoo Finance
How Vir found the one: CEO Marianne De Backer - Fierce Biotech
Fierce Biotech
Vir Biotechnology Announces CFO Departure and Board Expansion - TipRanks.com - TipRanks
TipRanks
大文字化:
|
ボリューム (24 時間):